Table 1. | Expression levels and localization of BiP/GRP78 and calnexin in KCOTs, PACs and FBs |
Specimen No. |
Age | BiP/GRP78 expression intensity |
BiP/GRP78 expression localization |
Calnexin expression intensity |
Calnexin expression localization |
---|---|---|---|---|---|
KCOTs | |||||
1 | 47 | - | + | FT | |
2 | 74 | + | FT | ± | FT |
3 | 58 | + | FT | ± | FT |
4 | 40 | - | - | ||
5 | 65 | ++ | UL | - | |
6 | 62 | - | - | ||
7 | 60 | - | - | ||
8 | 43 | ++ | FT/UL | + | UL |
9 | 24 | +++ | UL | + | UL |
10 | 33 | ++ | FT/UL | + | UL |
11 | 51 | ++ | FT/UL | ++ | FT/UL |
12 | 70 | - | - | ||
13 | 66 | - | - | ||
14 | 44 | + | FT | - | |
15 | 40 | ± | FT | ± | FT |
16 | 46 | + | FT | - | |
17 | 47 | + | FT | + | FT |
18 | 8 | ++ | FT/UL | + | FT |
19 | 28 | ++ | FT | ++ | FT |
20 | 57 | + | FT | ± | FT |
21 | 48 | + | FT | - | |
22 | 45 | + | UL | - | |
23 | 75 | + | FT/UL | - | |
24 | 32 | + | FT | - | |
PACs | |||||
1 | 57 | + | FT | ± | FT |
2 | 45 | - | - | ||
3 | 32 | - | - | ||
4 | 30 | - | - | ||
5 | 53 | - | - | ||
6 | 40 | - | - | ||
7 | 52 | - | - | ||
8 | 40 | - | - | ||
9 | 45 | - | - | ||
FBs | |||||
1 | 10 | - | - | ||
2 | 56 | - | - | ||
3 | 67 | - | - | ||
4 | 50 | - | - | ||
5 | 34 | - | - |
KCOTs = keratocystic odontogenic tumors; PACs = periapical or radicular cysts; FBs = fibromas; FT = full thickness of the epithelium; UL = upper layers; FT/UL = full thickness with stronger intensity in the upper layers. |